At least six foreign managers are expected to launch QDLP products in China this year.

At least six foreign managers are expected to launch QDLP products in China this year.
The Korean asset manager has diversified away from its recent passive fund focus with offerings of two actively-managed growth equity products.
Seven firms received the quotas for the first time.
It has also plans of applying for a QDLP licence.
For Asia as a whole, the firm has set an AUM objective of €500bn ($582.75bn).
Mainland investors have favoured onshore funds as the domestic market continues to outperform the rest of the world.
It wants to join forces with a local firm to tap into the country’s growing financial services sector.
Import substitution and market consolidation is transforming China’s healthcare sector, according to JP Morgan Asset Management.
The sector is expected to deliver earnings growth of 25-30% in the next 12-18 months.
High returns, low correlations and index inclusion should attract foreign flows into China Government Bonds (CGBs), says Fidelity’s Asia CIO.
Part of the Mark Allen Group.